Dr. Singerman recently returned from the annual Association for Research in Vision and Ophthalmology (ARVO) meeting held in Baltimore, MD, where he and other members of the CLEAR Study Group presented results from an observational study that evaluated the agreement between standard vision assessment tools and the Paxos Mobile App in visual acuity and Amsler grid testing.
The clinical trial, sponsored by Digisight Technologies, was completed in April 2017. Other members of the CLEAR Study Group include ophthalmologists Dr. Khurana of CA, Dr. Khanani from NV, and Dr. Holcomb and Dr. Hoang, both from Digisight Technologies in San Francisco.
ARVO is the largest gathering of eye and vision researchers in the world, attracting over 11,000 attendees from more than 75 countries. About 45% of the attendees are from outside the U.S.